JP2016533856A5 - - Google Patents

Download PDF

Info

Publication number
JP2016533856A5
JP2016533856A5 JP2016543402A JP2016543402A JP2016533856A5 JP 2016533856 A5 JP2016533856 A5 JP 2016533856A5 JP 2016543402 A JP2016543402 A JP 2016543402A JP 2016543402 A JP2016543402 A JP 2016543402A JP 2016533856 A5 JP2016533856 A5 JP 2016533856A5
Authority
JP
Japan
Prior art keywords
agents
administered
active agent
drug delivery
active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016543402A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016533856A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2014/069916 external-priority patent/WO2015040122A1/en
Publication of JP2016533856A publication Critical patent/JP2016533856A/ja
Publication of JP2016533856A5 publication Critical patent/JP2016533856A5/ja
Pending legal-status Critical Current

Links

JP2016543402A 2013-09-20 2014-09-18 条件付きの必須プライミング Pending JP2016533856A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13185258.4 2013-09-20
EP13185258 2013-09-20
PCT/EP2014/069916 WO2015040122A1 (en) 2013-09-20 2014-09-18 Conditional required priming

Publications (2)

Publication Number Publication Date
JP2016533856A JP2016533856A (ja) 2016-11-04
JP2016533856A5 true JP2016533856A5 (OSRAM) 2017-10-19

Family

ID=49322146

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016543402A Pending JP2016533856A (ja) 2013-09-20 2014-09-18 条件付きの必須プライミング

Country Status (6)

Country Link
US (1) US20160213849A1 (OSRAM)
EP (1) EP3046604B1 (OSRAM)
JP (1) JP2016533856A (OSRAM)
CN (1) CN105555340A (OSRAM)
HK (1) HK1226003A1 (OSRAM)
WO (1) WO2015040122A1 (OSRAM)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3063015B1 (fr) * 2017-02-20 2021-10-01 Aptar France Sas Dispositif d'injection automatique de produit fluide.

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5378231A (en) * 1992-11-25 1995-01-03 Abbott Laboratories Automated drug infusion system
US6554798B1 (en) * 1998-08-18 2003-04-29 Medtronic Minimed, Inc. External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities
DE19840992A1 (de) * 1998-09-08 2000-03-09 Disetronic Licensing Ag Drucküberwachung eines bei einer Infusion oder Injektion dosiert zu verabreichenden Produktfluids
US8308457B2 (en) * 2004-11-24 2012-11-13 Q-Core Medical Ltd. Peristaltic infusion pump with locking mechanism
EP2389207B1 (en) * 2009-01-22 2016-12-14 Medtronic, Inc. User interface indicating fluid location for an implantable fluid delivery device
EP4324499A3 (en) * 2009-03-25 2024-04-24 DEKA Products Limited Partnership Infusion pump methods and systems
WO2010125154A1 (en) * 2009-04-30 2010-11-04 Sanofi-Aventis Deutschland Gmbh Pen-type injector with ergonomic button arrangement
US9114212B2 (en) * 2009-07-08 2015-08-25 Novo Nordisk A/S Auto-priming injection device
JP6047097B2 (ja) * 2010-10-31 2016-12-21 トラスティーズ オブ ボストン ユニバーシティ 血糖制御システム
US10251583B2 (en) * 2010-12-22 2019-04-09 Roche Diabetes Care, Inc. Insulin pump and methods for operating the insulin pump
WO2012126745A2 (en) * 2011-03-18 2012-09-27 Gambro Lundia Ab Methods and devices for operating an infusion system
JP6239501B2 (ja) * 2011-05-24 2017-11-29 デカ・プロダクツ・リミテッド・パートナーシップ 血液処置システムおよび方法
JP6055819B2 (ja) * 2011-05-25 2016-12-27 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 薬剤注射デバイスおよびプライミング動作
US20140276536A1 (en) * 2013-03-14 2014-09-18 Asante Solutions, Inc. Infusion Pump System and Methods
US9446186B2 (en) * 2013-03-01 2016-09-20 Bigfoot Biomedical, Inc. Operating an infusion pump system

Similar Documents

Publication Publication Date Title
JP2016532516A5 (OSRAM)
JP2016221392A5 (OSRAM)
MY174727A (en) Stable, protracted glp-1/glucagon receptor co-agonists for medical use
JP2014141525A5 (OSRAM)
EA201401028A1 (ru) Фармацевтическая композиция, содержащая эмпаглифлозин и лекарственное средство от ожирения
MX2022011334A (es) Tratamiento de la enfermedad de fabry en pacientes no tratados y tratados previamente con ert.
HK1245153A1 (zh) Btk抑制剂组合和给药方案
JP2015522522A5 (OSRAM)
MX2017008000A (es) Sistema de inyeccion de un solo uso.
EA201501164A1 (ru) Твердая фармацевтическая лекарственная форма
AR091621A1 (es) Formas de presentacion farmaceuticas que contienen 5-cloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morfolinil)-fenil]-1,3-oxazolidin-5-il}-metil)-2-tiofen-carboxamida
PH12016502233A1 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
MX2016012052A (es) Dimetilfumarato y regimenes de vacunacion.
GB2534488A (en) Measured dose dispenser
JP2016533856A5 (OSRAM)
TW201642854A (en) Fixed dose combination for pain relief without edema
MX387263B (es) Composición farmacéutica de liberación prolongada que comprende cisteamina o sal de la misma.
WO2016077565A3 (en) Methods for chronic pain management and treatment using hcg
PH12018500889A1 (en) Pharmaceutical preparation for delivery of porous material to large intestine or lower part of small intestine
MX391734B (es) COMPOSICIÓN FARMACÉUTICA QUE COMPRENDE IgG PARA EL TRATAMIENTO DE UNA INMUNODEFICIENCIA.
Hopkins New drugs and dosage forms
RU2017140779A (ru) Композиции для лечения рака
Boga Various toxicities: 2 case reports
CN302470054S (zh) 注入器（微注入器）
Stepanov et al. Experience of Vasonat usage in treatment of patients with chronic toxic hepatitis